1-Methyl-3-(4-{[3-(pyridin-4-yl)pyrazin-2-yl]oxy}phenyl)-1H-pyrrolo[3,2-b]quinoline

ID: ALA3315039

Chembl Id: CHEMBL3315039

PubChem CID: 118707960

Max Phase: Preclinical

Molecular Formula: C27H19N5O

Molecular Weight: 429.48

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2ccc(Oc3nccnc3-c3ccncc3)cc2)c2nc3ccccc3cc21

Standard InChI:  InChI=1S/C27H19N5O/c1-32-17-22(26-24(32)16-20-4-2-3-5-23(20)31-26)18-6-8-21(9-7-18)33-27-25(29-14-15-30-27)19-10-12-28-13-11-19/h2-17H,1H3

Standard InChI Key:  GPWJHAOLOAZQJW-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3315039

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 429.48

Molecular Weight (Monoisotopic): 429.1590

AlogP: 6.04

#Rotatable Bonds: 4

Polar Surface Area: 65.72

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 4.49

CX LogP: 4.96

CX LogD: 4.96

Aromatic Rings: 6

Heavy Atoms: 33

QED Weighted: 0.34

Np Likeness Score: -0.73

References

1. Das S, Shelke DE, Harde RL, Avhad VB, Khairatkar-Joshi N, Gullapalli S, Gupta PK, Gandhi MN, Bhateja DK, Bajpai M, Joshi AA, Marathe MY, Gudi GS, Jadhav SB, Mahat MY, Thomas A..  (2014)  Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: part II.,  24  (15): [PMID:24980052] [10.1016/j.bmcl.2014.06.028]

Source

Source(1):

• Scientific Literature